Quorum Health Corporation has successfully completed its financial restructuring and emerged from the Chapter 11 process in U.S. Bankruptcy Court for the District of Delaware. The Company announced that Martin D. Smith is being elevated to President and Chief Operating Officer. Mr. Smith, who joined Quorum Health upon its formation in 2016, previously served as its Executive Vice President and Chief Operations Officer. He will maintain operations and management responsibility for the Company’s 22 hospitals. Alfred Lumsdaine will continue to serve as Executive Vice President and Chief Financial Officer. The Company’s reconstituted Board of Managers will be led by Catherine Klema. Ms. Klema is President of Nettleton Advisors, a financial advisory and strategic consulting company assisting healthcare clients. In addition to Ms. Klema and Mr. Jacobs, the new Board of Managers will be comprised of the following individuals: Murtaza Ali – Mr. Ali is an Operating Partner at Davidson Kempner Hawthorne Partners LP. Previously, he was a senior operating partner at BlueMountain Capital and a Managing Director at Anchorage Capital, overseeing value creation efforts across a range of industries including real estate, health care and business services. Earlier in his career, Mr. Ali held various leadership roles at the Boston Consulting Group, Target and McKinsey. Michael Rothbart – Mr. Rothbart currently serves as a Senior Research Analyst at GoldenTree Asset Management where he maintains a focus on health care and technology industries. Alice Schroeder – Ms. Schroeder, who has served on Quorum Health’s Board since 2018. Andrew E. Schultz – Mr. Schultz is a managing member of Woodbine Consulting, LLC, and a member of Holding Capital Group. Dan Slipkovich – Mr. Slipkovich has more than 35 years of experience leading multi-billion-dollar hospital operations in senior leadership roles. On July 7, 2020, pursuant to the Plan, Robert H. Fish, Joseph A. Hastings, D.M.D., Jon H. Kaplan, Barbara R. Paul, M.D., Terry Allison Rappuhn, William P. Rutledge, Alice D. Schroeder, and R. Lawrence Van Horn, Ph.D. resigned from the QHC Board. As of the Effective Date, Robert H. Fish resigned as President of QHC and as an officer and director of any of QHC’s subsidiaries.